The SYNJ1 gene helps nerve cells recycle the tiny membrane bubbles they use to send signals. This gene plays an important role in keeping synapses, the contact points between nerve cells, working smoothly. If it does not work properly, some people may develop early seizures, developmental delay, movement problems, or a form of early-onset Parkinson disease.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or to regulate processes throughout the body. Some genes carry the directions for producing proteins, which are the parts of cells that do the work. Others are used mainly to manage when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you react to food, stress, and medicines. More detail is available in the LearnHub.
Overview
SYNJ1Gene function
What if the gene works
The SYNJ1 gene helps nerve cells recycle the tiny membrane sacs that release chemical signals. This supports smooth communication between brain cells and helps keep the cell membrane’s signaling fats in balance.
Risk
What if the gene does not work
Variants in the SYNJ1 gene can cause early-onset brain conditions, including developmental delay with seizures and, in some people, young-onset parkinsonism. Milder and more severe variants may affect when symptoms begin, how severe they are, and which features appear.
Treatment
What does that mean for your treatment
No treatment or drug choice is currently guided specifically by a pathogenic or loss-of-function variant in the SYNJ1 gene. Care is based on symptoms, with medicines and therapies chosen for seizures, movement problems, or developmental needs. The SYNJ1 gene is being studied in Parkinson disease and epilepsy research as a possible biomarker and treatment target.
Conditions associated with SYNJ1
Gene function
What if the gene works
Nerve cells send messages in tiny packets that are used again and again. The SYNJ1 gene helps keep that cycle moving by reshaping cell membranes and clearing used packets for reuse. This is part of how nerve cells recycle messenger packets and stay ready for the next signal.
Inside your cells, the SYNJ1 gene helps remove small chemical tags from membrane fats. This resets the membrane after a packet forms and helps it bend, pinch, and recover in a controlled way.
After a nerve cell releases a message, the SYNJ1 gene helps the used membrane fold back in and form a reusable packet. It also helps that packet lose its temporary protein coat so it can be refilled and used again.
By supporting quick packet reuse, this gene helps nerve cells stay ready to send signals over and over. That supports smooth communication in busy parts of the brain and nervous system.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, including variation in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, however, a variant can change how a gene functions more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SYNJ1 gene can change how the synaptojanin-1 protein folds, how stable it is, and how well it carries out its enzyme job. Some SYNJ1 gene variants leave partial activity, while more disruptive variants can sharply reduce the protein level or largely stop its activity, which can interfere with vesicle recycling (the reuse of tiny sacs that release signals between nerve cells). In general, milder changes may have a smaller functional effect, while more severe loss-of-function variants are linked to earlier and more pronounced neurologic disease.
How variants are linked to conditions
Pathogenic variants in the SYNJ1 gene can cause two main inherited conditions: an early infantile developmental and epileptic encephalopathy, with seizures and delayed development starting in infancy, and a rarer early-onset Parkinson disease with movement symptoms beginning much earlier than usual. This summary of variants in the SYNJ1 gene linked to Parkinson disease and infantile epilepsy reflects the strongest human genetics evidence.
A variant is not necessarily a diagnosis
Genetic variants are a common, normal feature of human biology and are found across the general population. Most do not have a direct effect on health and simply contribute to natural differences among people. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when multiple genes and environmental influences are involved. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the SYNJ1 gene. In families with a disease-causing SYNJ1 change, risk is mainly shaped by the inherited variant itself rather than lifestyle, and a doctor or genetic counselor can help explain personal and family risk.
Inheritance of SYNJ1 variants
SYNJ1-related conditions are inherited in an autosomal recessive pattern. In practical terms, how SYNJ1 variants are inherited usually means a child receives one altered copy of the SYNJ1 gene from each parent. Parents who each carry one variant are often unaffected themselves, and with each pregnancy there is a 25% chance the child inherits both altered copies, a 50% chance the child is a carrier, and a 25% chance the child inherits neither altered copy. This pattern affects boys and girls equally.
What does my SYNJ1 result mean for my family?
For SYNJ1, family implications usually fit a recessive pattern. This often means both parents are healthy carriers, brothers and sisters may also be affected or may be carriers, and other relatives may want to know whether they carry the same change. For many living with a SYNJ1-related condition, children are usually carriers unless the other parent also carries a SYNJ1 change.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the SYNJ1 gene, genetic testing for variants in the SYNJ1 gene reads your DNA from a blood sample, saliva sample, or cheek swab. Results can show whether a variant is present and may help explain symptoms or confirm a diagnosis in someone with a matching clinical picture.
When should I consider getting a genetic test?
Genetic testing for the SYNJ1 gene may be worth considering if a baby or child has very early seizures, major delays in development, weak muscle tone, or unusual movement problems, especially when similar symptoms run in the family. It can also be considered in families with very early-onset Parkinson-like symptoms.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains varies by the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body functions over time. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it into tissues, or responds to it at its target. This helps explain why the same medicine may work well for one person, do less for another, or cause more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. By looking at relationships between genes and drugs, it helps explain why the same treatment can work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body handles it. This information can support more informed, more individualized treatment choices. To explore this topic in greater detail, you can learn more in the LearnHub.
Drugs influenced by the SYNJ1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used, so any questions about symptoms, treatment, or side effects are best discussed with your doctor or pharmacist.
History
The SYNJ1 gene entered the scientific literature in the mid 1990s, when researchers identified synaptojanin 1 while studying proteins involved in nerve cell signaling. From these first observations, research expanded steadily. Early work placed SYNJ1 in the growing field of brain cell communication and helped connect it to the tiny recycling steps that keep nerve endings working. In the 2010s, pathogenic variants in the SYNJ1 gene were linked to rare inherited neurological conditions, including forms of early onset Parkinsonism and developmental and epileptic encephalopathy. These discoveries gave the gene a clearer place in medical genetics. Over time, descriptions became more precise as genetic studies linked different SYNJ1 variants with a range of neurologic features.